Non-pharmacological treatment of idiopathic pulmonary fibrosis

被引：0
作者：
Huzaifa I. Adamali
Muhammad S. Anwar
Anne-Marie Russell
Jim J. Egan
机构：
[1] Southmead Hospital,North Bristol Lung Centre
[2] Chest Medicine,Interstitial Lung Disease Unit
[3] St Mary’s Hospital,National Advanced Lung Disease and Lung Transplant Programme
[4] Royal Brompton Hospital,undefined
[5] Mater Misericordiae University Hospital,undefined
[6] University College Dublin,undefined
来源：
Current Respiratory Care Reports | 2012年 / 1卷 / 4期
关键词：
Idiopathic pulmonary fibrosis; Transplantation; Lung transplant; Pulmonary rehabilitation; Oxygen therapy; Palliation; Palliative care; Advance care planning; Advance directive;
D O I：
10.1007/s13665-012-0031-z
中图分类号：
学科分类号：
摘要：
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fatal disorder that remains difficult to treat. In this review, we examine non-pharmacological treatment modalities, including lung transplantation, pulmonary rehabilitation and palliation. Lung transplantation, the only therapeutic intervention that offers survival benefit, should be considered in all IPF patients with progressive disease who meet the International Society for Heart and Lung transplantation guidelines. Pulmonary rehabilitation improves exercise capacity, reduces dyspnoea and improves quality of life in IPF patients, and should be made available to patients. For those patients with advanced disease, palliative services offer symptom management, improved quality of life and psychological support for patients and their caregivers.
引用
收藏
页码：208 / 215
页数：7
相关论文
共 210 条
[1]  
Raghu G(2011)An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med. 183 788-824
[2]  
Collard HR(2007)Organ allocation in lung transplant Chest 132 1646-1651
[3]  
Egan JJ(2011)The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart–Lung Transplant Report—2011 J Heart Lung Transplant. 30 1123-1132
[4]  
Davis SQ(2009)The impact of the lung allocation scoring system at the single national Veterans Affairs Hospital lung transplantation program Eur J Cardiothorac Surg. 36 497-501
[5]  
Garrity ER(2000)Lung transplantation is warranted for stable, ventilator-dependent recipients Ann Thorac Surg 70 1675-1678
[6]  
Christie JD(2009)Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis Ann Thorac Surg 88 1757-1764
[7]  
Edwards LB(2006)International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation J Heart Lung Transplant. 25 745-755
[8]  
Kucheryavaya AY(2007)Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report—2007 J Heart Lung Transplant. 26 782-795
[9]  
Osaki S(2006)Quantitative analysis of fibroblastic foci in usual interstitial pneumonia Chest 130 22-29
[10]  
Maloney JD(2002)The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis Am J Respir Crit Care Med. 15 173-177
12345678910